TimothySavageMDMPH, MSc

Investigator | Pediatric Infectious Diseases Physician

Dr. Savage is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Harvard School of Public HealthMPH, Clinical effectiveness, 2019 - 2021
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2018 - 2021
University of WashingtonChief Residency, Pediatrics, 2017 - 2018
University of WashingtonResidency, Pediatrics, 2014 - 2017
Icahn School of Medicine at Mount SinaiClass of 2014

Maxwell Finland Award for Research Excellence in Fellowship Massachusetts Infectious Disease Society, 2020
Faculty Teaching Honor Roll Boston Combined Residency Program in Pediatrics, 2020
Trainee Award ID Week, 2020
Resident Physician Family Centered Care Award Seattle Children's Hospital Family Advisory Council, 2017
Member Gold Humanism Honor Society, 2014
Graduation Speaker Icahn School of Medicine at Mount Sinai, 2014
Best Master's Thesis Icahn School of Medicine at Mount Sinai, 2010
Join now to see all

PubMed

19 citations
Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019.
Jeffrey I Campbell, Melanie M Dubois, Timothy J Savage, M Indriati Hood-Pishchany, Tanvi S Sharma
The Journal of Pediatrics. 2022-06-01
389 citations
DENV inhibits type I IFN production in infected cells by cleaving human STING.
Sebastian Aguirre, Ana M. Maestre, Sarah Pagni, Jenish R. Patel, Timothy Savage
Plos Pathogens. 2012-10-04
1 citations
Baseline stool toxin concentration is associated with risk of recurrence in children withinfection.
Thomas J Sandora, Larry K Kociolek, David N Williams, Kaitlyn Daugherty, Christine Geer
Infection Control and Hospital Epidemiology. 2023-09-01